RBC Capital analyst Ben Hendrix maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $58.00.

Three prominent investment firms bet changes are in the offing at ailing healthcare giant CVS Health and added to existing ...

Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

2 Beaten-Down Dividend Stocks to Buy and Hold was originally published by The Motley Fool Despite soft inflation print, bond ...

Taking into account the latest results, the current consensus from CVS Health's 23 analysts is for revenues of US$385.9b in ...

At CVS Health, automation transcends mere enhancement; it is the strategic bedrock upon which the company rapidly meets ...

Congress may approve stronger pharmacy benefit manager rules after years of debate, in part to cover the cost of Medicare ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

We recently compiled a list of the Jim Cramer Talked About These 16 Stocks. In this article, we are going to take a look at ...

Among the gains in the contract are the elimination of two-tier wage scale and an increased health care bonus.

A number of analysts have downgraded estimates for CVS Health CVS following the pharmacy benefit and retail pharmacy stalwart ...